ECSDI045123S - - Google Patents

Info

Publication number
ECSDI045123S
ECSDI045123S EC2004005123F ECSDI045123F ECSDI045123S EC SDI045123 S ECSDI045123 S EC SDI045123S EC 2004005123 F EC2004005123 F EC 2004005123F EC SDI045123 F ECSDI045123 F EC SDI045123F EC SDI045123 S ECSDI045123 S EC SDI045123S
Authority
EC
Ecuador
Application number
EC2004005123F
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSDI045123S publication Critical patent/ECSDI045123S/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EC2004005123F 2001-11-26 2004-05-26 ECSDI045123S (enEXAMPLES)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26

Publications (1)

Publication Number Publication Date
ECSDI045123S true ECSDI045123S (enEXAMPLES) 2004-07-23

Family

ID=23302492

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2004005123F ECSDI045123S (enEXAMPLES) 2001-11-26 2004-05-26
EC2004005123A ECSP045123A (es) 2001-11-26 2004-05-26 Composición para catéteres y sus usos

Family Applications After (1)

Application Number Title Priority Date Filing Date
EC2004005123A ECSP045123A (es) 2001-11-26 2004-05-26 Composición para catéteres y sus usos

Country Status (28)

Country Link
US (3) US20030206906A1 (enEXAMPLES)
EP (1) EP1455858A4 (enEXAMPLES)
JP (1) JP4458240B2 (enEXAMPLES)
KR (2) KR20100102745A (enEXAMPLES)
CN (1) CN100478027C (enEXAMPLES)
AR (1) AR037437A1 (enEXAMPLES)
AU (2) AU2002365408B2 (enEXAMPLES)
BR (1) BR0215098A (enEXAMPLES)
CA (1) CA2467645C (enEXAMPLES)
CO (1) CO5580795A2 (enEXAMPLES)
EA (1) EA007594B1 (enEXAMPLES)
EC (2) ECSDI045123S (enEXAMPLES)
HR (1) HRP20040502A2 (enEXAMPLES)
HU (1) HUP0600436A3 (enEXAMPLES)
IL (2) IL162083A0 (enEXAMPLES)
IS (1) IS7275A (enEXAMPLES)
ME (1) ME00015B (enEXAMPLES)
MX (1) MXPA04004948A (enEXAMPLES)
MY (1) MY140404A (enEXAMPLES)
NO (1) NO331700B1 (enEXAMPLES)
NZ (1) NZ533029A (enEXAMPLES)
PL (1) PL371760A1 (enEXAMPLES)
RS (1) RS46204A (enEXAMPLES)
TW (1) TWI262794B (enEXAMPLES)
UA (1) UA81235C2 (enEXAMPLES)
UY (1) UY27550A1 (enEXAMPLES)
WO (1) WO2003045466A2 (enEXAMPLES)
ZA (1) ZA200404024B (enEXAMPLES)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100102745A (ko) 2001-11-26 2010-09-24 제넨테크, 인크. 카테터 조성물 및 그의 용도
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
CA2662083C (en) * 2006-08-28 2016-09-20 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
ES2451015T3 (es) * 2006-08-28 2014-03-26 Omnio Healer Ab Candidatos contra la infección
JP5871449B2 (ja) * 2006-11-07 2016-03-01 ジェネンテック, インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用
RU2323001C1 (ru) * 2007-05-30 2008-04-27 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая фибринолитическим действием
WO2008150375A1 (en) 2007-06-01 2008-12-11 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
EP2200650B1 (en) * 2007-09-07 2016-01-06 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
EP3307374A4 (en) 2015-06-11 2019-04-10 Proviflo, LLC GRAFT-PORT HEMODIALYSIS SYSTEMS, DEVICES AND METHODS

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484A7 (fi) 1982-05-05 1983-11-06 Genentech Inc Ihmiskudoksen plasminogeenien aktivaattori.
US5000185A (en) 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
WO1991017724A1 (en) 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
JP3559559B2 (ja) * 1992-06-03 2004-09-02 ジェネンテク,インコーポレイテッド 向上した治療特性を有する組織プラスミノーゲン活性化因子グリコシル化変異体
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5362754A (en) 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
US5849736A (en) 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
HUT74690A (en) 1993-11-24 1997-01-28 Du Pont Merck Pharma Novel isoxazoline and isoxazole fibrinogen receptor antagonists process for producing them and pharmaceutical compositions containing them
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
WO1998028326A1 (en) 1996-12-23 1998-07-02 Biochem Pharma Inc. Bicyclic thrombin inhibitors
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
IL144798A0 (en) 1999-03-11 2002-06-30 Du Pont Pharm Co Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
AR022909A1 (es) 1999-03-11 2002-09-04 Du Pont Pharm Co Sinergia entre heparina de bajo peso molecular e inhibidores de la agregacion plaquetaria, que provee una terapia combinada para la prevencion ytratamiento de diversas afecciones tromboembolicas
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
ATE394134T1 (de) 2000-05-10 2008-05-15 Ash Access Technology Inc Kathetersperrlösung mit photo-oxidant
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
KR20100102745A (ko) 2001-11-26 2010-09-24 제넨테크, 인크. 카테터 조성물 및 그의 용도
US20070014779A1 (en) 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
EP1442753B1 (en) 2003-02-03 2007-02-21 Polaschegg, Hans-Dietrich, Dr.techn. Composition for the prevention of indwelling device related infection
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
JP5871449B2 (ja) 2006-11-07 2016-03-01 ジェネンテック, インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用

Also Published As

Publication number Publication date
WO2003045466A2 (en) 2003-06-05
US20030206906A1 (en) 2003-11-06
TW200303743A (en) 2003-09-16
KR20100102745A (ko) 2010-09-24
ZA200404024B (en) 2005-07-27
HUP0600436A3 (en) 2010-12-28
NZ533029A (en) 2006-05-26
RS46204A (en) 2006-10-27
CN1617738A (zh) 2005-05-18
MY140404A (en) 2009-12-31
ME00015B (me) 2010-06-10
NO331700B1 (no) 2012-02-27
IL162083A0 (en) 2005-11-20
MXPA04004948A (es) 2004-08-11
AU2002365408A1 (en) 2003-06-10
PL371760A1 (en) 2005-06-27
AU2008203131A1 (en) 2008-08-07
US7829082B2 (en) 2010-11-09
AR037437A1 (es) 2004-11-10
MEP8008A (xx) 2010-02-10
UY27550A1 (es) 2003-06-30
HUP0600436A2 (en) 2006-09-28
BR0215098A (pt) 2004-12-14
KR20040054803A (ko) 2004-06-25
CO5580795A2 (es) 2005-11-30
JP2005510302A (ja) 2005-04-21
CA2467645A1 (en) 2003-06-05
CN100478027C (zh) 2009-04-15
AU2002365408B2 (en) 2008-04-24
CA2467645C (en) 2017-01-17
EA007594B1 (ru) 2006-12-29
EA200400712A1 (ru) 2005-06-30
TWI262794B (en) 2006-10-01
EP1455858A2 (en) 2004-09-15
UA81235C2 (en) 2007-12-25
NO20042693L (no) 2004-08-25
US20060257390A1 (en) 2006-11-16
EP1455858A4 (en) 2006-02-15
WO2003045466A3 (en) 2003-10-09
HRP20040502A2 (en) 2004-12-31
JP4458240B2 (ja) 2010-04-28
IS7275A (is) 2004-05-21
IL162083A (en) 2012-12-31
ECSP045123A (es) 2004-07-23
US20060246050A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
BE2022C531I2 (enEXAMPLES)
BE2022C502I2 (enEXAMPLES)
BE2022C547I2 (enEXAMPLES)
BE2017C059I2 (enEXAMPLES)
BE2011C034I2 (enEXAMPLES)
BE2007C047I2 (enEXAMPLES)
AU2002307149A8 (enEXAMPLES)
BE2014C006I2 (enEXAMPLES)
JP2002168661A5 (enEXAMPLES)
JP2002245775A5 (enEXAMPLES)
BRPI0209186B1 (enEXAMPLES)
BE2016C043I2 (enEXAMPLES)
CH1379220H1 (enEXAMPLES)
JP2001225819A5 (enEXAMPLES)
JP2002031931A5 (enEXAMPLES)
BRPI0101486B8 (enEXAMPLES)
JP2002236419A5 (enEXAMPLES)
BE2012C051I2 (enEXAMPLES)
ECSDI045123S (enEXAMPLES)
BRPI0210463A2 (enEXAMPLES)
AU2000280389A8 (enEXAMPLES)
JP2002056487A5 (enEXAMPLES)
JP2002206566A5 (enEXAMPLES)
JP2002229704A5 (enEXAMPLES)
JP2002207158A5 (enEXAMPLES)